Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease (2015)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.1007/s12017-015-8361-y
- Subjects: DOENÇA DE ALZHEIMER; INFLAMAÇÃO; BIOMARCADORES; DOENÇAS NEURODEGENERATIVAS (FISIOPATOLOGIA); LÍQUIDO CEFALORRAQUIDIANO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Neuromolecular Medicine
- ISSN: 1535-1084
- Volume/Número/Paginação/Ano: v. 17, n. 3, p. 326-332, 2015
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FORLENZA, Orestes Vicente et al. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease. Neuromolecular Medicine, v. 17, n. 3, p. 326-332, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007/s12017-015-8361-y. Acesso em: 18 abr. 2024. -
APA
Forlenza, O. V., Diniz, B. S., Teixeira, A. L., Radanovic, M., Talib, L. L., Rocha, N. P., & Gattaz, W. F. (2015). Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease. Neuromolecular Medicine, 17( 3), 326-332. doi:10.1007/s12017-015-8361-y -
NLM
Forlenza OV, Diniz BS, Teixeira AL, Radanovic M, Talib LL, Rocha NP, Gattaz WF. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2015 ; 17( 3): 326-332.[citado 2024 abr. 18 ] Available from: http://link.springer.com/article/10.1007/s12017-015-8361-y -
Vancouver
Forlenza OV, Diniz BS, Teixeira AL, Radanovic M, Talib LL, Rocha NP, Gattaz WF. Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2015 ; 17( 3): 326-332.[citado 2024 abr. 18 ] Available from: http://link.springer.com/article/10.1007/s12017-015-8361-y - Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- A radioenzymatic assay to identify three groups of phospholipase A2 in platelets
- Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
- Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
- Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients
- Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
Informações sobre o DOI: 10.1007/s12017-015-8361-y (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
